Company / Current Liabilities per Share
Entera Bio Ltd. Current Liabilities per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.06
FY2025
5-year range
$0.03 / $0.15
FY2021-FY2025
Trend
+71.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share returned to growth in FY2025 after 3 years of decline, reaching $0.06.
Based on SEC 10-K filings.
0.06 in FY2025 with a 3-year CAGR of +6.8%.
Increased from $0.04 to $0.06 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +6.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share increased 71.1% year-over-year.
- Peak current liabilities per share was recorded in FY2021.
- Lowest current liabilities per share in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -0.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.06 | +71.1% |
| FY2024 | $0.03 | -12.5% |
| FY2023 | $0.04 | -18.7% |
| FY2022 | $0.05 | -69.0% |
| FY2021 | $0.15 | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026